Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
Trinity Capital Inc.
TRIN
$1.55B
| $126K | ﹤0.01% |
11,547
-16,850
| -59% | -$196K |
|
|
CZOO
5302
DELISTED
Cazoo Group Ltd
CZOO
| $125K | ﹤0.01% |
400
| – | – |
|
5303
China Automotive Systems
CAAS
$131M
| $125K | ﹤0.01% |
+21,589
| New | +$111K |
|
|
BNR
5304
Burning Rock Biotech
BNR
$93.7M
| $125K | ﹤0.01% |
+5,545
| New | +$126K |
|
5305
Aemetis
AMTX
$109M
| $124K | ﹤0.01% |
31,437
+3,685
| +13% | +$20.9K |
|
|
RVPH
5306
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $124K | ﹤0.01% |
+1,461
| New | +$111K |
|
|
NEXN
5307
Nexxen International
NEXN
$583M
| $123K | ﹤0.01% |
19,119
-8,201
| -30% | -$60K |
|
5308
Vertical Aerospace
EVTL
$166M
| $123K | ﹤0.01% |
3,629
-4,196
| -54% | -$223K |
|
5309
Kamada
KMDA
$414M
| $123K | ﹤0.01% |
30,575
-10,593
| -26% | -$46.7K |
|
5310
Hagerty
HGTY
$1.38B
| $122K | ﹤0.01% |
14,551
-24,023
| -62% | -$209K |
|
5311
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$23.5M
| $122K | ﹤0.01% |
+76
| New | +$161K |
|
5312
Nature's Sunshine
NATR
$360M
| $122K | ﹤0.01% |
14,638
-10,768
| -42% | -$91.2K |
|
|
TRHC
5313
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $121K | ﹤0.01% |
24,399
+6,597
| +37% | +$27.2K |
|
5314
RUM Group Inc
RUM
$1.71B
| $119K | ﹤0.01% |
20,062
-29,945
| -60% | -$287K |
|
|
UHG
5315
DELISTED
United Homes Group
UHG
| $119K | ﹤0.01% |
11,843
| – | – |
|
|
RSX
5316
DELISTED
VanEck Russia ETF
RSX
| $119K | ﹤0.01% |
20,978
| – | – |
|
5317
Ouster
OUST
$3.04B
| $118K | ﹤0.01% |
13,708
+1,324
| +11% | +$14.4K |
|
5318
908 Devices
MASS
$345M
| $118K | ﹤0.01% |
15,478
-14,748
| -49% | -$178K |
|
5319
Humacyte
HUMA
$197M
| $117K | ﹤0.01% |
55,594
-16,164
| -23% | -$49.1K |
|
|
KCGI
5320
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
| $116K | ﹤0.01% |
11,375
| – | – |
|
5321
Viant Technology
DSP
$246M
| $116K | ﹤0.01% |
28,771
-6,364
| -18% | -$25.7K |
|
5322
SelectQuote
SLQT
$122M
| $115K | ﹤0.01% |
171,176
+36,350
| +27% | +$23.8K |
|
|
EEX
5323
DELISTED
Emerald Holding
EEX
| $115K | ﹤0.01% |
32,484
-50
| -0.2% | -$179 |
|
5324
Direxion Daily Retail Bull 3X ETF
RETL
$30.4M
| $115K | ﹤0.01% |
16,512
+4,494
| +37% | +$34.9K |
|
5325
UNIFI
UFI
$123M
| $115K | ﹤0.01% |
13,313
-13,364
| -50% | -$115K |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.